Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management

NCT ID: NCT04711577

Last Updated: 2021-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-08

Study Completion Date

2021-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to understand users' experiences and interests completing self-tracking in a mobile intervention for binge eating and weight management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Binge Eating

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Condition 1

Track clinician-determined symptoms

Group Type EXPERIMENTAL

Track clinician-determined symptoms

Intervention Type BEHAVIORAL

Participants will track clinician-determined symptoms

Condition 2

Track clinician-determined and self-determined symptoms

Group Type EXPERIMENTAL

Track clinician-determined and self-determined symptoms

Intervention Type BEHAVIORAL

Participants will track clinician-determined symptoms and a self-determined symptom

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Track clinician-determined symptoms

Participants will track clinician-determined symptoms

Intervention Type BEHAVIORAL

Track clinician-determined and self-determined symptoms

Participants will track clinician-determined symptoms and a self-determined symptom

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age 18 years or older
* Obesity (BMI ≥30)
* Recurrent binge eating (≥12 episodes in the past 3 months)
* Interested in losing weight and reducing binge eating
* Willing to use a mobile application
* Willing to practice self-monitoring
* Has access to a scale
* Not pregnant
* English-speaking

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Graham

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU00213531

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Meditation-Based Treatment for Binge Eating Disorder
NCT00032760 COMPLETED PHASE2/PHASE3
Treatment of Binge Eating Disorder
NCT00041743 COMPLETED NA
Treatment of Binge Eating Disorder
NCT00039936 COMPLETED NA
Personalized Treatment
NCT04183894 COMPLETED NA